Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters - Wikidata - wikimedia - TriplyDB

Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters

Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters

http://www.wikidata.org/entity/Q42846067

about

Biofilm and Helicobacter pylori: from environment to human host Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.Mechanical integrity of hemodialysis catheters after exposure to a novel catheter lock solution Role of antibiofilm-antimicrobial agents in controlling device-related infections.Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial.Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice N-acetylcysteine lock solution prevents catheter-associated bacteremia in rabbits In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.Foreign body infections due to Staphylococcus epidermidis.Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis Mini-review: Antimicrobial central venous catheters--recent advances and strategies.Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection.Antibiofilm agents and implant-related infections in orthopaedics: where are we?Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.Drug treatments for prosthetic joint infections in the era of multidrug resistance.Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm.Tigecycline: Alone or in combination?Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.Emergency 1-stage anterior approach for cervical spine infection complicated by epidural abscess.Effect of different agents with potential antibiofilm activity on antimicrobial susceptibility of biofilms formed by Staphylococcus spp. isolated from implant-related infections.Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms.Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells.Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study.Bacterial translocation across ePTFE vascular graft surfaces Efficacy of acidic and basic electrolyzed water in eradicating Staphylococcus aureus biofilm.Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices.Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia.Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model.Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects.In vitro effects of N-acetylcysteine alone and combined with tigecycline on planktonic cells and biofilms of Acinetobacter baumannii.

P2860

Q27015096-D1F5384E-B4ED-4C23-B3DF-DA3971378BBC Q30403958-4042A2FF-24EA-4A19-90AD-487F67E6FF5C Q30433594-B114718C-B052-42F3-916D-287D175809F7 Q33696391-6482AF8A-FF8A-4D7B-A47A-B5638F207F8B Q34077214-A2EBCDA6-16A3-481B-AE62-066483DF2061 Q34252915-AF57E2E0-CA9B-4EBA-8ED3-2AE32D85BEA0 Q34304343-9B32ECCA-AC67-4487-B027-D7C26683B0E3 Q35941476-2424BB35-3ADC-4E0A-84F3-13497D834DDA Q37116666-5826CF58-60E7-488A-853F-52C174C28B54 Q37197429-5FC7D789-A618-4906-8803-D9AFAB65C819 Q37249440-9495431E-20A1-4688-A0C4-593979A44274 Q37322685-E6921307-D347-4CD2-9D7E-B37CDBEA0A24 Q37409869-1FB4567B-4AAE-4B49-931B-CDEDF45508BE Q37896090-2D87EF9B-1F5A-4CFF-86C0-303F39BFDFC0 Q38014922-35BC4FE7-0984-4AFE-A929-50D683B6C8DE Q38107655-FB638D1B-AE25-4C82-9899-50452A71C771 Q38166786-5B0F0BFC-8998-430E-926B-2E0BAC682016 Q38182646-512113B9-CE4C-4D0B-90E9-2D64322D6946 Q38536137-4A1AEC16-52CE-4064-B015-90677D28CB2F Q38800556-BA284698-F459-4660-95FD-28870A203527 Q39501793-20244A2B-BC0C-429E-833C-7FD46343C3B3 Q39916184-F811C163-2B37-4456-A7BE-12D6CF224BC6 Q40072216-519DEEED-5855-4C42-91C2-2448BC73A341 Q40154965-DA9235E7-6153-4915-979D-75F7D7380B87 Q40780892-ADAE0A98-D979-40C7-B867-D576A2365865 Q41725795-6BF71654-DDF1-4347-8378-DC5DCEA89CF8 Q41838275-0C1B6578-02DE-4BBC-8293-88F0810A53D3 Q42103662-FAFFE68E-4660-4131-B808-345FED342EE7 Q42218026-4E3BDCA1-42DE-41E1-9290-681A6A4A1A11 Q42325197-87F139E6-8F36-4B22-AF93-AAC76E075A5F Q42592964-A03052CA-3320-4D80-8216-7301DFD2C70F Q44522479-CF00A335-3925-4B6D-BEEE-B5EAFB2C0A6A Q46193541-0AEDD897-C103-42EB-BD02-2BFC25D5AE62 Q46471711-D6F5247A-2708-4B73-A24D-E8C7BEA00164 Q47689699-B125ED36-B333-4AAF-AAAA-AB0364695583 Q48139465-CDEF4F8A-ED12-427A-ABF2-4B043F3895C9 Q48523183-7B42FD35-7DBB-4371-BB4D-19854F7F73BD Q54698100-AC0F9D59-03B0-4080-AAC9-FE30584B0D82 Q55266091-826F2234-741D-4F17-8A96-B0542D531120

P2860

Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters

http://www.wikidata.org/entity/Q42846067

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Combination of tigecycline and ...... bacteria on vascular catheters

@en

Combination of tigecycline and ...... bacteria on vascular catheters

@nl

type

label

Combination of tigecycline and ...... bacteria on vascular catheters

@en

Combination of tigecycline and ...... bacteria on vascular catheters

@nl

prefLabel

Combination of tigecycline and ...... bacteria on vascular catheters

@en

Combination of tigecycline and ...... bacteria on vascular catheters

@nl

P1433

Q42846067-35FAC1DB-5EDB-49EB-8089-CA990405D290

P1476

Q42846067-6B400F22-7A49-4374-BAA8-6AE870BEAE54

P2093

Q42846067-590CC17C-0BB0-43E2-92D8-4E9F071DB0ED

Q42846067-6747E364-B7CC-4CE6-8EC8-9FC9DA3CE78E

Q42846067-9450F45F-0A4C-4DB6-AE70-AECDF5141726

Q42846067-F5ECD113-9298-4D8C-8263-BF809D1603B8

P2860

Q42846067-075385C0-8893-467D-8875-1A9A379C3184

Q42846067-167892BD-EE7A-4E45-8D35-CCAD98763638

Q42846067-2161D365-C92A-4CE9-93A4-C609B3AA1702

Q42846067-30D0E60D-2348-4BE9-AFD5-CBD87B512CFA

Q42846067-3493C9EA-FCFD-4698-96D4-552E53EAEC47

Q42846067-3A3DE8B4-B387-42BC-B451-01CC67C6E785

Q42846067-436604E1-15A4-41AB-82E5-4209A0F495E0

Q42846067-48FC7CE6-1A59-407F-91E1-501BA2457164

Q42846067-5C1D20B3-318F-412A-AA9E-086040625CA7

Q42846067-64A5BB7E-EF63-48EC-A23B-770FF132B4F5

P304

Q42846067-95B87297-219F-40CD-920D-7EBBE218221A

P31

Q42846067-AFA1DA3B-8FC4-4148-B3A5-6051B141B2FD

P356

Q42846067-B4C484A4-DA30-4235-9D90-4584B4BC263A

P407

Q42846067-4F1850B3-1C70-4156-A771-2D6FECBDA3B5

P433

Q42846067-F9B6ADEE-7334-4434-B9CD-CCB77A92CC29

P478

Q42846067-E8F6DBA3-489D-41C4-9DF6-4AED7EA034BC

P577

Q42846067-11741CCE-F66C-4E73-9F30-59F66C8EC603

P5875

Q42846067-153DC4C9-24AB-41E7-88BF-80E2719A9E2C

P698

Q42846067-FB27B9DD-3E4B-4F6F-933D-2D324534D9E4

P921

Q42846067-2C549211-C8A2-495A-9945-C7ACA1B8B7C7

Q42846067-5B64E0D7-D700-467C-81D4-96E7591B38CF

P932

Q42846067-30DFD501-0A30-40C5-B68A-B1FD5BFE4AC9

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Combination of tigecycline and ...... bacteria on vascular catheters

@en

P2093

Barbara W Trautner

http://www.w3.org/2001/XMLSchema#string

Rabih O Darouiche

http://www.w3.org/2001/XMLSchema#string

Saima Aslam

http://www.w3.org/2001/XMLSchema#string

Venkat Ramanathan

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci

In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces

Guidelines for the management of intravascular catheter-related infections.

Catheter-associated infections: pathogenesis affects prevention

Device-associated infections: a macroproblem that starts with microadherence.

What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?

Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.

An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children.

Antimicrobial activity of a novel catheter lock solution.

N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces.

P304

1556-1558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00893-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6582092

http://www.w3.org/2001/XMLSchema#string

P698

17220399

http://www.w3.org/2001/XMLSchema#string

P921

P932

1855497

http://www.w3.org/2001/XMLSchema#string